Offerpad Solutions Inc. (OPAD) Q3 2026 Earnings Call Transcript

Business & Economy

What to know

  • "@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage": "@type":"WebPage","@id":"https://seekingalpha.com/article/4961295-offerpad-solutions-inc-opad-q3-2026-earnings-call-transcript" ,"author": "@type":"Person","name":"SA Transcripts","url":...S1
  • "@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage": "@type":"WebPage","@id":"https://seekingalpha.com/article/4961199-biomarin-pharmaceutical-inc-bmrn-q3-2026-earnings-call-transcript" ,"author": "@type":"Person","name":"SA Transcripts","...S2
  • Vertex Pharmaceuticals Incorporated (VRTX) Q3 2026 Earnings Call TranscriptS3
  • Harmonic Inc. (HLIT) Q3 2026 Earnings Call TranscriptS4
  • Production grew 6% as debt fell $500 million, signaling improved momentum.S5
  • Revenue fell 52% on delivery timing, but debt dropped 55% and guidance rose on margins.S6
  • Lymphedema revenue surged 13% as Medicare prior authorization stabilized.S7
  • Redemption revenue surged 23% as publisher network hit all-time high redeemers.S8
  • AI initiatives and higher-value clients drive $185.6M revenue amid marketplace pressures.S9
  • Record revenue surged 151% year-over-year as both distribution channels scaled rapidly.S10
Timeline · newest first
3h Seekingalpha

Offerpad Solutions Inc. (OPAD) Q3 2026 Earnings Call Transcript

"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage": "@type":"WebPage","@id":"https://seekingalpha.com/article/4961295-offerpad-solutions-inc-opad-q3-2026-earn…

3h Seekingalpha

BioMarin Pharmaceutical Inc. (BMRN) Q3 2026 Earnings Call Transcript

"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage": "@type":"WebPage","@id":"https://seekingalpha.com/article/4961199-biomarin-pharmaceutical-inc-bmrn-q3-2026…

3h Fool

Kosmos Energy (KOS) Q3 2026 Earnings Call Transcript

Production grew 6% as debt fell $500 million, signaling improved momentum.

4h Fool

Emergent BioSolutions (EBS) Q3 2026 Earnings Call Transcript

Revenue fell 52% on delivery timing, but debt dropped 55% and guidance rose on margins.

4h Fool

Tactile (TCMD) Q3 2026 Earnings Call Transcript

Lymphedema revenue surged 13% as Medicare prior authorization stabilized.

4h Fool

Ibotta (IBTA) Q3 2026 Earnings Call Transcript

Redemption revenue surged 23% as publisher network hit all-time high redeemers.

4h Fool

Upwork (UPWK) Q3 2026 Earnings Call Transcript

AI initiatives and higher-value clients drive $185.6M revenue amid marketplace pressures.

4h Fool

Ethos (LIFE) Q3 2026 Earnings Call Transcript

Record revenue surged 151% year-over-year as both distribution channels scaled rapidly.

4h Fool

SI-BONE (SIBN) Q3 2026 Earnings Call Transcript

Procedure volume surged 20% as active physicians hit record 1,770.

4h Fool

Inspire (INSP) Q3 2026 Earnings Call Transcript

Reimbursement headwinds cut Q3 revenue, but 2027 outlook improves.

4h Fool

Ichor (ICHR) Q3 2026 Earnings Call Transcript

Revenue surged 37% year-over-year as margins expanded and earnings doubled sequentially.

4h Fool

Match (MTCH) Q3 2026 Earnings Call Transcript

Tinder DAU returns to growth after 3.5 years; Hinge revenue surges 19% YoY.

4h Fool

Gaia (GAIA) Q3 2026 Earnings Call Transcript

Revenue fell 12% as Gaia prioritizes high-value direct subscribers over volume.

4h Fool

Waystar (WAY) Q3 2026 Earnings Call Transcript

Subscription bookings surged 34% as AI capabilities drove adoption gains.

4h Fool

Travere (TVTX) Q3 2026 Earnings Call Transcript

FILSPARI sales hit $200.2 million as FSGS launches alongside sustained IgAN demand.

Offerpad Solutions Inc. (OPAD) Q3 2026 Earnings Call Transcript

2 outlets 22 reports

What to know

  • "@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage": "@type":"WebPage","@id":"https://seekingalpha.com/article/4961295-offerpad-solutions-inc-opad-q3-2026-earnings-call-transcript" ,"author": "@type":"Person","name":"SA Transcripts","url":...S1
  • "@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage": "@type":"WebPage","@id":"https://seekingalpha.com/article/4961199-biomarin-pharmaceutical-inc-bmrn-q3-2026-earnings-call-transcript" ,"author": "@type":"Person","name":"SA Transcripts","...S2
  • Vertex Pharmaceuticals Incorporated (VRTX) Q3 2026 Earnings Call TranscriptS3
  • Harmonic Inc. (HLIT) Q3 2026 Earnings Call TranscriptS4
  • Production grew 6% as debt fell $500 million, signaling improved momentum.S5
  • Revenue fell 52% on delivery timing, but debt dropped 55% and guidance rose on margins.S6
  • Lymphedema revenue surged 13% as Medicare prior authorization stabilized.S7
  • Redemption revenue surged 23% as publisher network hit all-time high redeemers.S8
  • AI initiatives and higher-value clients drive $185.6M revenue amid marketplace pressures.S9
  • Record revenue surged 151% year-over-year as both distribution channels scaled rapidly.S10
Timeline · newest first

Sources · 10 citations

S1S2S3S4 Seekingalpha 9 reports · EN
S5S6S7S8S9S10 FoolLead 13 reports · EN